Abstract
Bipolar disorder (BD) is a major public health problem associated with significant functional impairment. Despite recent advances, the molecular mechanisms underlying BD remain unclear. Cumulative evidence from research studies, including those from our laboratory, has shown that the regulation of energy metabolism through mitochondrial electron transport chain and alterations in calcium voltage-dependent channels may be central to the pathophysiology of BD. In fact, patients with BD present an increase in markers of oxidative damage to lipids, proteins, and DNA in both central and peripheral samples followed by increased intracellular levels of calcium. In theory, calcium might trigger mitochondrial dysfunction, which in turn leads to an increase in the production of reactive oxygen species and its consequent oxidative stress damage to biomolecules. Therefore, this chapter will discuss the recent findings of oxidative stress and mitochondrial dysfunction in BD and how calcium alterations play a role in this scenario.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Bipolar Disorder
- Mitochondrial Dysfunction
- Reactive Nitrogen Species
- Mitochondrial Electron Transport Chain
- Young Mania Rate Scale
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Introduction
Bipolar disorder (BD) is characterized by mood fluctuations between episodes of mania and depression. It is also characterized by a larger loss of disability-adjusted life-years than all forms of cancer or major neurologic conditions (Merikangas et al. 2011), which elevates the health-care costs four times higher than that of the general population (Altamura et al. 2011). Therefore, BD is becoming a foremost health concern. The complex pathophysiology of BD has brought interest in several areas of research to investigate the causes and consequences of this mood fluctuation to the brain.
Several hypotheses have been postulated during this journey to identify the etiology and pathophysiology of BD, which includes inflammatory responses (Goldstein et al. 2009), genetic modifications (Schulze 2010), alteration in calcium signaling (Kato 2008a ), and decrease of density and size of neurons and glia (for review see Gigante et al. 2010). Mitochondrial dysfunction, mitochondrial DNA abnormalities, protein expression of mitochondrial electron transport chain, reduced pH, and decreased levels of high-energy phosphates in the brain, as well as increased oxidative stress status, have been a common feature identified in several recent investigations carried out on patients with BD (Andreazza et al. 2008; Clay et al. 2010). Therefore, mitochondrial dysfunction and the consequent oxidative damage to biomolecules could be associated with the verified neuronal or glial impairment in BD (Beal 2002; Clay et al. 2010; Gigante et al. 2010). In the following section of this chapter, the most relevant results to date for BD and how calcium plays a role in this scenario will be discussed.
2 Evidence of Oxidative Stress in Bipolar Disorders
The central nervous system presents high amounts of oxidizable substrates, high oxygen tension, and relatively low antioxidant capacity making it extremely vulnerable to oxidative damage (Halliwell and Whiteman 2004; Sies 1991). When the cytoplasmic enzymatic and nonenzymatic antioxidant and mitochondria systems are overwhelmed by high levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS), the DNA, lipids, and proteins can be damaged (Lenaz 2001).
Mitochondria are intracellular organelles that play a crucial role in ATP production carried out by the electron transport chain (ETC) complexes I, II, III, IV, and V in the inner membrane through a process known as oxidative phosphorylation (Chinopoulos and Adam-Vizi 2010). Mitochondria are not only essential for energy control but also for maintaining calcium homeostasis (Kato 2008b), regulating apoptosis, and generating reactive oxygen species (ROS) (Jeong and Seol 2008). ATP production occurs through the flow of electrons along ETC complexes transferring protons across the inner membrane, producing a large mitochondrial membrane potential. The energy lost by the reentering protons in the mitochondrial matrix, through the ATP synthase protein, is used to form ATP (Green and Kroemer 2004; Lenaz 2001; Reeve et al. 2008). Single electrons escape during the ETC transfer, resulting in a single electron reduction of molecular oxygen forming superoxide anion (O2 −), especially in complex I (NADH:ubiquinone oxidoreductase) (Green and Kroemer 2004). Superoxide dismutase (SOD) converts the mitochondrial O2 − into hydrogen peroxide (H2O2), which in the presence of ferrous iron (Fe+2) results in the production of hydroxyl radicals (OH•) via Fenton reaction (H2O2 + Fe+2 → Fe+3 + OH− + OH•). Another relevant event is the reaction of O2 •− with nitric oxide (NO•), reactive nitrogen species produced by microglia and astrocytes, to form peroxynitrite (ONOO−) (Naoi et al. 2005).
2.1 Protein Oxidation
Proteins can have their structure and functionality modified by oxidative damage (Beal 2002; Lee et al. 2009). In BD, many proteins are targets for oxidative damage, which may include synaptic function key proteins, such as synaptophysin (Mallozzi et al. 2009). The mitochondrial ETC proteins are more vulnerable to nitrosative damage, suggesting a functional relationship between mitochondrial dysfunction and nitrosative damage (Murray et al. 2003).
In the hippocampus of patients with BD, the neuronal nitric oxide synthase I, the enzyme that generates NO•, was found to be upregulated, in addition to increased serum levels of NO• in subjects with the same disorder (Selek et al. 2008). Protein oxidative damage can be induced by reaction with hydroxyl free radical (OH•), which is catalyzed by Fe+2 and Cu+2, introducing carbonyl groups (Beal 2002). Protein nitration occurs by reaction of ONOO− with sulfhydryl and hydroxyl residues (Naoi et al. 2005). Such modifications might inactivate the membrane signaling pathways and key enzymes (Naoi et al. 2005). The tyrosine residues nitration produces 3-nitrotyrosine in proteins that serves as a marker of ONOO− oxidative damage induced in vivo (Naoi et al. 2005). This oxidative damage affects protein functionality, altering, for example, enzyme activities (Beal 2002), and susceptibility to proteolytic degradation (Naoi et al. 2005).
Results from our group reported increased levels of 3-nitrotyrosine in postmortem prefrontal cortex (Andreazza et al. 2010) and also found increased serum levels of 3-nitrotyrosine in patients with BD in both early (0–3 years) and late (10–20 years) stages of the illness (Andreazza et al. 2009). In addition, other evidences give support to the vulnerability of mitochondrial protein to nitrosative damage. A functional relationship between complex I activity and nitration was shown in mitochondrial membranes from bovine heart, where ONOO− targeted mainly complex I subunits, resulting in significant inhibition of complex I activity (Murray et al. 2003). This is further supported by the report by Naoi et al. (2005) of increased 3-nitrotyrosine levels in the mitochondrial complex I subunits, but not other mitochondrial proteins, and of SH-SY5Y cells incubated with ONOO−. Other studies demonstrated increase of the oxidative stress markers such as protein carbonylation, lipid peroxidation, and 3-nitrotyrosine levels in the brain and peripheral blood cells of BD subjects (Machado-Vieira et al. 2007; Wang et al. 2009; Andreazza et al. 2009, 2010).
2.2 DNA Oxidation
DNA is also vulnerable to oxidative damage; hydroxyl radicals react with DNA causing single- or double-strand breaks (Halliwell and Gutteridge 2007) or promote oxidation to C-8 position of deoxyguanosine on DNA, forming 8-hydroxy-2-deoxyguanosine (8-OHdG). DNA oxidation can also be induced by ONOO−, which forms strand breaks and base oxidation products and cause deamination of G and A leading to formation 8-nitro-deoxyguanosine (Burcham and Harkin 1999). DNA lesions are rapidly detected by the DNA damage response system (Barzilai and Yamamoto 2004). This response culminates in activation of cell-cycle checkpoints and the appropriate DNA repair pathways (Iliakis et al. 2003). Oxidative DNA damage is mostly repaired by base excision repair (BER) and nucleotide excision repair (NER) enzymes (Halliwell and Gutteridge 2007). Most of the damage is removed before the cell reach replication preventing damage transmission to new cells (Evans et al. 2000). If this system is overwhelmed by free radicals, mutations to adenine or cytosine (A:T to G:C or G:C to T:A transversion mutations) will occur and consequently activate the apoptosis machinery (Halliwell and Gutteridge 2007).
Recently, oxidative stress and deficiency of oxyguanosine DNA glycosylase 1 (Ogg1), an enzyme responsible to repair the damage resulting from 8-OHdG, are considered to be a crucial factor in the process of aging and aging-related diseases, such as Alzheimer (Mao et al. 2007). Mitochondrial oxidative phosphorylation subunits are assembled from proteins encoded in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). Complex I is assembled from 45 subunits, 7 of those are encoded by mtDNA and the rest by nDNA; complex II is formed from 4 nDNA polypeptides; complex III has 11 subunits and cytochrome C is encoded by mtDNA; and complex IV also has only one subunit from the 13 encoded by mtDNA (Wallace 2010). Therefore, to maintain an efficient energetic metabolism, the cells have to protect both mtDNA and nDNA from damage. Damage to mtDNA and nDNA can lead to various levels of mitochondrial dysfunction (loss of control, but still functional) and disorder (loss of functionality) (Campbell and Mahad 2012).
mtDNA mutation rate is usually higher than nDNA, which can be due to the lack of protection from histones and the proximity to mitochondrial ROS production (Wallace 2010). It is reasonable to expect that mtDNA repair system would be higher than nDNA. On the other hand, the cells do not invest just enough energy to save the mtDNA till cell reproduction or death (Wallace 2007). Thus, it has been observed that mtDNA has higher levels of oxidation than nDNA (Bohr and Dianov 1999). The importance of mtDNA to keep a healthy CNS is highlighted by the number of mtDNA disorders, where complex II (nDNA) is spared. The section “Mitochondrial Dysfunction” of this chapter will describe the findings of mitochondrial DNA mutation in BD. Andreazza et al. (2008) have demonstrated an increased DNA fragmentation in lymphocytes from patients with BD during different episodes of the diseases. Additionally, Andreazza et al. (2008) reported a positive correlation between Young Mania Rating Scale (YMRS) and the intensity of DNA damage, highlighting the importance of illness severity for these findings. The technique used in this study was COMET assay, which is an easy method to detect DNA double- and single-strand breaks or damage. Interestingly, BD is associated with other known DNA damage diseases as cardiovascular, diabetes, and obesity. Che et al. (2010) found elevated oxidative damage to nucleic acids (8-hydroxy-2’-deoxyguanosine) in CA1, CA3, and dentate gyrus regions of the hippocampus among patients with BD, schizophrenia (SCZ), and major depressive disorder (MDD). Supporting the involvement of DNA damage in BD, Buttner et al. (2007) demonstrated increased DNA fragmentation in non-GABAergic neurons in postmortem anterior cingulate cortex from patients with BD. Finally the authors suggested that the increased DNA damage may be attributed to high oxidative stress associated with BD.
Telomere shortening has been a well-thought-out sign of growing oxidative stress and a marker of antioxidant defense capacity (Saretzki and Von Zglinicki 2002). Passos et al. (2007) utilized the replicative senescence model as a reliable cellular model of aging. He verified that mitochondrial generation of ROS is crucial for determining telomere shortening. To further support the accumulative effect of oxidative damage occurring in BD, Simon et al. (2006) found that the amount of telomere shortening in patients with chronic mood disorders corresponds to 10 years of accelerated aging. As Higuchi (2004) stated that oxidative DNA damage is an intermediate step to cellular apoptosis and knowing that telomeres are located in the end of mammalian chromosomes, it is believed that the link between mitochondrial ETC dysfunction, oxidative stress, DNA damage, and cell death is a promising field in the investigation of the pathophysiology of BD.
3 Sources of Oxidative Stress Damage in Bipolar Disorder
3.1 Mitochondrial Dysfunction
Mitochondrial dysfunction (MD) is a dysregulation of the ETC complex, which can be caused by genetic alteration; different toxins capable of inhibiting mitochondrial ETC complex, such as 6-hydroxydopamine, a sub-product of dopamine oxidation; or simply impaired activity (Halliwell and Whiteman 2004). BD may be associated with the susceptibility of oxidative stress; a downregulation of several complex I subunits occurs in BD. Human complex I is composed of 45–46 different subunits and divided into three functional modules (dehydrogenase, hydrogenase, and transporter). Finally, the transporter module is responsible for translocation of protons across the membrane (Brandt et al. 2003). Interestingly, Iwamoto et al. (2004) and Sun et al. (2006) reported that NDUFV2, NDUFS1, NDUFS7, and NDUFS8 present decreased expression in BD in the dehydrogenase module. These results suggest that patients with BD may have reduced ability to oxidize NADH and to transfer electrons to ubiquinone. This means that O2 − is produced because electrons may persist for sufficient time to react with molecular oxygen (Boveris and Chance 1973; Turrens and Boveris 1980; Andreazza et al. 2010). Together, the organization of complex I, downregulation of complex I subunits, and diminished antioxidant levels support the susceptibility of proteins from mitochondrial oxidative damage in BD. These oxidations on protein residues can alter protein function or lead to deleterious intermolecular aggregates (Beal 2002). Decreased expression of genes involved in proteasome degradation process was found in the prefrontal cortex of subjects with BD, suggesting a faster accumulation of carbonylated proteins (Konradi et al. 2004). The etiology and/or progression of several chronic central nervous system disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis, is associated with the accumulation of carbonylated proteins (Castegna et al. 2002a, b).
Many lines of studies suggest that MD plays a role in BD pathophysiology. In 1995, McMahon et al. (1995) speculated that mtDNA and imprinted DNA can be inherited from the mother and increase 1.3- to 2.5-fold the risk of illness for the offspring of affected mothers. Additionally, a deletion on mtDNA of 4,977 bp, known as the “common deletion,” was reported to be associated with BD and SCZ. In the cortex of BD probands and suicide victims, significant increases in the prevalence of the common deletion were found (Kato et al. 1997). Kakiuchi et al. (2005) reported controversial results failing to find the association of common deletion levels with BD and schizophrenia individuals. Another genetic alteration is the polymorphism in the mt-ND1 gene (366T>C), supporting the involvement of mtDNA mutations in ETC functionality, associated with BD. The mt-ND1 alteration causes a decreased mitochondrial membrane potential and complex I activity (Munakata et al. 2004). A decreased mitochondrial matrix pH has been linked to 10398A>G polymorphism in BD and, also, to higher baseline and poststimulation mitochondrial Ca2+ levels (Kato and Kato 2000; Kato et al. 2003; Kazuno et al. 2006, 2008). Interestingly, mtDNA copy number can be modulated by the energy requirement for the cell. For example, Liu et al. (2003) reported that human leukocytes increase the mtDNA copy number in response to oxidative stress. Wallace (2007) reported that mutation in mtDNA accumulated with the aging process and might be a response to increment of oxidative damage during this process.
For instance, in BD, many mRNAs coding for electron ETC complexes I–V subunits, especially complex I, presented decreased expression (Clay et al. 2010). Postmortem hippocampus (Konradi et al. 2004) and frontal cortex (Iwamoto et al. 2005; Sun et al. 2006) revealed decreased expression of several mRNAs coding for ETC complexes I–V subunits by DNA microarray analyses. Iwamoto et al. (2005) reported that mRNA levels in the prefrontal cortex of subjects with BD such as complex I subunit NDUFS1, complex III subunit UQCRC2, and complex IV subunit COX15 were decreased. Konradi et al. (2004) also identified nuclear mRNA coding for mitochondrial proteins and genes regulating oxidative phosphorylation and the adenosine triphosphate-dependent process of proteasome degradation. Sun et al. (2006) reported a downregulation of 8 mitochondrial ETC-related genes, using high-density cDNA spot microarrays, consisting of NDUFS7 and NDUFS8 (complex I), UQCRC2 (complex III), COX5A and COX6C (complex IV), and ATP5C1 and ATP5J (complex V) and confirmed that mRNA levels of NDUFS7 were decreased using real-time quantitative PCR. Moreover, evidence from several genotyping studies suggest that polymorphisms of complex I subunit NDUFV2 may be associated with BD, thus supporting the involvement of mitochondrial complex I dysfunction in BD (Xu et al. 2008; Washizuka et al. 2009). Moreover, other recent studies in subjects with BD have demonstrated alterations in a diverse set of oxidative stress parameters, such as alterations in antioxidant enzymes (Kuloglu et al. 2002; Savas et al. 2006; Andreazza et al. 2008), increased lipid peroxidation (Kuloglu et al. 2002; Savas et al. 2006; Machado-Vieira et al. 2007; Andreazza et al. 2008), increased DNA fragmentation (Andreazza et al. 2008; Buttner et al. 2007), and increased levels of nitric oxide (Savas et al. 2002; Selek et al. 2008) on peripheral blood cells. Oxidative damage modifies the structure and function of proteins, suggesting that such alterations might be connected with disease outcome (Beal 2002; Lee et al. 2009).
3.2 Calcium Metabolism
Several critical cellular responses are controlled by Ca2+, which is a key element in signal transduction (Murray et al. 2003). Thus, Ca2+ ion levels are transported across the plasma membrane and the membranes of intracellular organelles through a number of tightly controlled channels, pumps, and exchangers. Calcium is mainly buffered by two organelles: endoplasmic reticulum and mitochondria (Adam-Vizi and Starkov 2010). Growing attention has been put toward increasing the understanding of the mechanisms involved in Ca2+ ion uptake by the mitochondria. Mitochondrial machinery is activated by the accumulation of Ca2+ leading to increased ATP synthesis and ATP levels in the cytosol (Rizzuto et al. 1999). The accumulation of calcium accelerates H+ extrusion and activates oxidative phosphorylation (Hansford 1985; Santo-Domingo and Demaurex 2010), which can in turn increase ROS production (Adam-Vizi and Starkov 2010).
The ROS production induced by calcium can be triggered by different pathways including (1) activation of mitochondrial electron transport chain and thus increase the probability of leaking O2 − in mitochondrial complex I and complex III; (2) stimulation of nitric oxide synthase (NOS) that increases the production of NO∙ by catalyzing the oxidation of a guanidine nitrogen of L-arginine (L-Arg) producing L-arginine as an intermediate and NO∙ as a final product; and (3) stimulation of calcium-dependent endonucleases, which can induce DNA fragmentation, an important event in apoptosis. On the other hand, H2O2 can increase intracellular Ca2+ levels through the opening of TRPM2 cation channels resulting in cellular loss if not interrupted. The prolonged increase of Ca2+ can also induce mitochondrial permeability transition pore, leading to mitochondrial swelling and cytochrome C release resulting in cell death by apoptosis (Giorgi et al. 2012; Miller and Zhang 2011).
In BD, elevated intracellular Ca2+ and abnormal Ca2+ signaling have been recognized as markers (Kato 2008). The first report of elevated calcium concentration in BD was found in platelets (Dubovsky et al. 1994). Also, cells of patients afflicted with both depression and mania had increased free intracellular calcium ion concentrations (Dubovsky et al. 1994). Euthymic lithium-treated patients presented increased total serum and ionized calcium when compared to healthy controls (El Khoury et al. 2002). Besides, elevated basal calcium concentrations have been detected in transformed B lymphoblasts in BD-I compared with those with BD-II, major depression, or healthy controls (Emamghoreishi et al. 2000). In all mood states of BD, calcium homeostasis appears altered. Further, thrombin, serotonin (5-HT), and platelet activating factor (PAF) are agonist-induced calcium influx and are enhanced in cells derived from patients with BD regardless of the agonist used (Kato 2008). In peripheral blood cells of patients with BD, thapsigargin-induced cytosolic Ca2+ response was found to be increased (Hough et al. 1999; Kato et al. 2003; Perova et al. 2008). Perova and colleagues (2010) stimulated B lymphoblast cell lines from patients with BD-I with lysophosphatic acid (LPA), showing increased Ca2+ mobilization.
Another piece of evidence that supports the calcium involvement in BD come from genome-wide association studies (GWAS) and linkage studies. GWAS of large groups of patients and controls are a very promising strategy to identify relevant genetic biomarkers. GWAS meta-analyses showed that CACNA1C and ANK3 (ankyrin 3) are the major candidate risk loci in BD (Sklar et al. 2008; Ferreira et al. 2008; Kempton et al. 2009; Schulze et al. 2009; Bigos et al. 2010). CACNA1C gene encodes for the alpha-1 subunit of an L-type voltage-dependent calcium channel named Cav1.2. This gene, nearly 300 kb, including 44 invariants and 6 alternative exons with a coding region of over 8 kb is located on chromosome 12q13.3. Some studies showed in patients with BD intriguing associations between CACNA1C SNP Rs1006737 (A/A genotype) and higher gray matter volume (Kempton et al. 2009), increased gray matter density in the right amygdala and hippocampus with some equivocal results (Bigos et al. 2010), and increased limbic activity during an emotional or reward task in fMRI (Jogia et al. 2011).
Intracellular calcium levels are tightly regulated via L-type (cav1.2 and Cav1.3) calcium channels and consist of 24 transmembrane segments, which are activated by membrane depolarization and mediate cellular Ca2+ influx (Catterall 2000). Cav1.2 is a complex protein containing four subunits in the cardiac form (an α1 subunit of 190–250 kDa, a transmembrane disulfide-linked complex of α2 and δ subunits, a β intracellular subunit, and a γ transmembrane subunit) and three subunits in the neuronal form (α1, α2δ, β). The expression of voltage-dependent Ca2+ channels is regulated through the phosphorylation pathway by a second messenger-activated protein (Catterall 2000). Ser1928 in the C-terminal domain is a target for phosphorylation through protein kinase A (PKA) (De Jongh et al. 1996) and plays a pivotal role in the functionality of Cav1.2, at least, in the cardiac isoform, as α1C subunit was found to bind to calmodulin, modulating Ca2+-dependent inactivation and facilitation of the channel (Kameda et al. 2006). Supporting the integration between mitochondria and calcium channels, Koh et al. (2003), using myocytes from cerebral arteries, demonstrated that mitochondria sense IP3R-mediated sarcoplasmic reticulum Ca2+ release to control NF-кB-dependent Cav1.2 channel expression.
4 Concluding Remarks: Perspectives of Oxidative Stress
As described above, the regulation of energy metabolism through decreased mitochondrial electron transport chain functionality and consequent increased oxidative stress damage to lipids, proteins, and DNA, as well as calcium metabolism, may be central to the pathophysiology of BD (Fig. 1). Oxidative stress can cause structural modifications to DNA purine and pyrimidine bases or induce posttranslational modifications in proteins. Interestingly, epigenetic changes also play an important role in the etiology of BD. Epigenetics is characterized as a process that modifies gene expression through alteration in DNA methylation and chromatin structure without changing the genomic DNA sequence (Tseng et al. 2008). Using an epigenome-wide approach to verify DNA methylation of specific genes, Cui et al. (2007) found epigenetic differences at genes involved in neuronal development and loci implicated in oxidative stress and mitochondrial dysfunction. Recently, Nohesara et al. (2011) found that similar to their previous findings in the prefrontal cortex, MB-COMT promoter was hypomethylated (∼50 %) in DNA derived from the saliva in SCZ and BD, compared to controls.
Emerging evidence suggests an interaction between oxidative stress and DNA methylation (Yucel et al. 2008). Cytosine (i.e. 5-hydroxymethylcytosine) or guanine oxidation (i.e. 8-hydroxy-2’-deoxyguanosine) promotes DNA demethylation through decreasing the affinity of the methyl group binding to DNA CpG islands, thus inducing changes in the expression of several genes (Fig. 2). Therefore, future studies evaluating the connection between oxidative damage to DNA and DNA methylation are essential to explain whether the oxidative stress can play a role in the well know decreased gene expression in BD (Wang et al. 2009).
Our understanding of molecular defects leading to BD is limited, which significantly prevents the development of new treatments for this illness. The evolution of studies exploring the relationship among oxidative stress, DNA methylation, and gene expression will ultimately open avenues to the development of new strategies that may prevent oxidative stress damage to biomolecules, thus translating the knowledge from the bench to the clinic.
Abbreviations
- 5-HT:
-
Serotonin
- 5meOHC:
-
5-hydroxymethylcisteine
- 8-OHdG:
-
8-hydroxy-2-deoxyguanosine
- BD:
-
Bipolar disorder
- BER:
-
Base excision repair
- DNA:
-
Glycosylase 1
- ETC:
-
Electron transport chain
- GWAS:
-
Genome-wide association studies
- LPA:
-
Lysophosphatic acid
- MD:
-
Mitochondrial dysfunction
- MDD:
-
Major depressive disorder
- NER:
-
Nucleotide excision repair
- Ogg1:
-
Oxyguanosine
- PAF:
-
Platelet-activating factor
- PKA:
-
Protein kinase A
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- SCZ:
-
Schizophrenia
References
Adam-Vizi V, Starkov AA (2010) Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J Alzheimers Dis 20(Suppl 2):S413–S426
Altamura AC, Serati M, Albano A, Paoli RA, Glick ID, Dell’Osso B (2011) An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatry Clin Neurosci 261:489–508
Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA (2007a) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41:523–529
Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Goncalves CA, Kapczinski F (2007b) DNA damage in bipolar disorder. Psychiatry Res 153:27–32
Andreazza AC, Kauer-Sant’anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111:135–144
Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, Walz JC, Bond DJ, Goncalves CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34:263–271
Andreazza AC, Shao L, Wang JF, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67:360–368
Barzilai A, Yamamoto K (2004) DNA damage responses to oxidative stress. DNA Repair (Amst) 3:1109–1115
Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32:797–803
Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B, Hyde TM, Lipska BK, Kleinman JE, Weinberger DR (2010) Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 67:939–945
Bohr VA, Dianov GL (1999) Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81:155–160
Boveris A, Chance B (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134:707–716
Brandt U, Kerscher S, Drose S, Zwicker K, Zickermann V (2003) Proton pumping by NADH:ubiquinone oxidoreductase. A redox driven conformational change mechanism? FEBS Lett 545:9–17
Burcham PC, Harkin LA (1999) Mutations at G:C base pairs predominate after replication of peroxyl radical-damaged pSP189 plasmids in human cells. Mutagenesis 14:135–140
Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007) DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 93:33–41
Campbell GR, Mahad DJ (2012) Mitochondrial changes associated with demyelination: consequences for axonal integrity. Mitochondrion 2:173–179
Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002a) Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562–571
Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002b) Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82:1524–1532
Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521–555
Che Y, Wang JF, Shao L, Young T (2010) Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 35:296–302
Chinopoulos C, Adam-Vizi V (2010) Mitochondrial Ca2+ sequestration and precipitation revisited. FEBS J 277:3637–3651
Clay HB, Sillivan S, Konradi C (2010) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29:311–324
Cui J, Shao L, Young LT, Wang JF (2007) Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144:1447–1453
De Jongh KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, Catterall WA (1996) Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3’,5’-cyclic monophosphate-dependent protein kinase. Biochemistry 35:10392–10402
Dubovsky SL, Thomas M, Hijazi A, Murphy J (1994) Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 243:229–234
El Khoury A, Petterson U, Kallner G, Aberg-Wistedt A, Stain-Malmgren R (2002) Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 26:1063–1069
Emamghoreishi M, Li PP, Schlichter L, Parikh SV, Cooke R, Warsh JJ (2000) Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder. Biol Psychiatry 48:665–673
Evans MD, Cooke MS, Akil M, Samanta A, Lunec J (2000) Aberrant processing of oxidative DNA damage in systemic lupus erythematosus. Biochem Biophys Res Commun 273:894–898
Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:1056–1058
Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, Heinsen H, Lafer B (2010) Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14:1075–1089
Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, Suski JM, Wieckowski MR, Pinton P (2012) Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 1:77–85
Goldstein BI, Fagiolini A, Houck P, Kupfer DJ (2009) Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 11:657–662
Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626–629
Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine, 4th edn. Oxford University Press
Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231–255
Hansford RG (1985) Relation between mitochondrial calcium transport and control of energy metabolism. Rev Physiol Biochem Pharmacol 102:1–72
Higuchi Y (2004) Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8:455–464
Hough C, Lu SJ, Davis CL, Chuang DM, Post RM (1999) Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay. Biol Psychiatry 46:247–255
Iliakis G, Wang Y, Guan J, Wang H (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834–5847
Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9:406–416
Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14:241–253
Jeong SY, Seol DW (2008) The role of mitochondria in apoptosis. BMB Rep 41:11–22
Jogia J, Ruberto G, Lelli-Chiesa G, Vassos E, Maierú M, Tatarelli R, Girardi P, Collier D, Frangou S (2011) The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry 11:1070–1071
Kakiuchi C, Ishiwata M, Kametani M, Nelson C, Iwamoto K, Kato T (2005) Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 8:515–522
Kameda K, Fukao M, Kobayashi T, Tsutsuura M, Nagashima M, Yamada Y, Yamashita T, Tohse N (2006) CSN5/Jab1 inhibits cardiac L-type Ca2+ channel activity through protein-protein interactions. J Mol Cell Cardiol 40:562–569
Kato T (2008a) Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’? Trends Neurosci 31:495–503
Kato T (2008b) Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 44:92–102
Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180–190
Kato T, Stine OC, McMahon FJ, Crowe RR (1997) Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry 42:871–875
Kato T, Ishiwata M, Mori K, Washizuka S, Tajima O, Akiyama T, Kato N (2003) Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 6:379–389
Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, Yoneda M, Kato N, Miyawaki A, Kato T (2006) Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2:e128
Kazuno AA, Munakata K, Kato N, Kato T (2008) Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids. Int J Neuropsychopharmacol 11:71–78
Kempton MJ, Ruberto G, Vassos E, Tatarelli R, Girardi P, Collier D, Frangou S (2009) Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry 166:1413–1414
Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS (2003) Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 100:313–317
Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300–308
Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20:171–175
Lee JR, Kim JK, Lee SJ, Kim KP (2009) Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis. Arch Pharm Res 32:1109–1118
Lenaz G (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52:159–164
Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, Wei YH (2003) Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res 37:1307–1317
Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, Kapczinski F, Portela LV, Souza DO, Salvador M, Gentil V (2007) Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421:33–36
Mallozzi C, Ceccarini M, Camerini S, Macchia G, Crescenzi M, Petrucci TC, Di Stasi AM (2009) Peroxynitrite induces tyrosine residue modifications in synaptophysin C-terminal domain, affecting its interaction with src. J Neurochem 111:859–869
Mao G, Pan X, Zhu BB, Zhang Y, Yuan F, Huang J, Lovell MA, Lee MP, Markesbery WR, Li GM, Gu L (2007) Identification and characterization of OGG1 mutations in patients with Alzheimer’s disease. Nucleic Acids Res 35:2759–2766
McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo JR (1995) Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 56:1277–1286
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68:241–251
Miller BA, Zhang W (2011) TRP channels as mediators of oxidative stress. Adv Exp Med Biol 704:531–544
Munakata K, Suzuki T, Watanabe N, Nagai H, Kakishita M, Saeki S, Ogawa S (2004) Influence of epidural lidocaine injection on vecuronium-induced neuromuscular blockade. Masui 53:1377–1380
Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA (2003) Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278:37223–37230
Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 31:81–93
Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S, Abdolmaleky HM (2011) DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 45:1432–1438
Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, Wappler I, Birket MJ, Harold G, Schaeuble K, Birch-Machin MA, Kirkwood TB, von Zglinicki T (2007) Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 5:e110
Perova T, Wasserman MJ, Li PP, Warsh JJ (2008) Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder. Int J Neuropsychopharmacol 11:185–196
Perova T, Kwan M, Li PP, Warsh JJ (2010) Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers. Int J Neuropsychopharmacol 13(6):693–702. Epub 2009 Apr 29. doi 10.1017/S1461145709000261
Reeve AK, Krishnan KJ, Turnbull DM (2008) Age related mitochondrial degenerative disorders in humans. Biotechnol J 3:750–756
Rizzuto R, Pinton P, Brini M, Chiesa A, Filippin L, Pozzan T (1999) Mitochondria as biosensors of calcium microdomains. Cell Calcium 26:193–199
Santo-Domingo J, Demaurex N (2010) Calcium uptake mechanisms of mitochondria. Biochim Biophys Acta 1797:907–912
Saretzki G, Von Zglinicki T (2002) Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 959:24–29
Savas HA, Herken H, Yurekli M, Uz E, Tutkun H, Zoroglu SS, Ozen ME, Cengiz B, Akyol O (2002) Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 45:57–61
Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7:51–55
Schulze TG (2010) Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. Psychiatr Clin North Am 33:67–82
Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J, Breuer R, Schwarz M, Propping P, Nothen MM, Cichon S, Schumacher J, Rietschel M, McMahon FJ (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14:487–491
Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, Yumru M (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107:89–94
Sies H (1991) Oxidative stress: from basic research to clinical application. Am J Med 91:31S–38S
Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60:432–435
Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13:558–569
Sun X, Wang JF, Tseng M, Young LT (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 31:189–196
Tseng M, Alda M, Xu L, Sun X, Wang JF, Grof P, Turecki G, Rouleau G, Young LT (2008) BDNF protein levels are decreased in transformed lymphoblasts from lithium-responsive patients with bipolar disorder. J Psychiatry Neurosci 33:449–453
Turrens JF, Boveris A (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191:421–427
Wallace DC (2007) Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu Rev Biochem 76:781–821
Wallace DC (2010) Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 51:440–450
Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11:523–529
Washizuka S, Iwamoto K, Kakiuchi C, Bundo M, Kato T (2009) Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res 63:199–204
Xu C, Li PP, Kennedy JL, Green M, Hughes B, Cooke RG, Parikh SV, Warsh JJ (2008) Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. Bipolar Disord 10:105–110
Yucel K, Taylor VH, McKinnon MC, Macdonald K, Alda M, Young LT, MacQueen GM (2008) Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 33:361–367
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scola, G., Andreazza, A.C. (2015). Oxidative Stress in Bipolar Disorder. In: Dietrich-Muszalska, A., Chauhan, V., Grignon, S. (eds) Studies on Psychiatric Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0440-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0440-2_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0439-6
Online ISBN: 978-1-4939-0440-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)